These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29538045)

  • 1. Biologics in pediatric lung disease.
    McGhee SA
    Curr Opin Pediatr; 2018 Jun; 30(3):366-371. PubMed ID: 29538045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Biologics in Asthma.
    McGregor MC; Krings JG; Nair P; Castro M
    Am J Respir Crit Care Med; 2019 Feb; 199(4):433-445. PubMed ID: 30525902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives of childhood asthma treatment with biologics.
    Just J; Deschildre A; Lejeune S; Amat F
    Pediatr Allergy Immunol; 2019 Mar; 30(2):159-171. PubMed ID: 30444939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of biologic therapies for the management of pediatric asthma.
    Lovinsky-Desir S
    Pediatr Pulmonol; 2020 Mar; 55(3):803-808. PubMed ID: 31880870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics and biomarkers for asthma, urticaria, and nasal polyposis.
    Casale TB
    J Allergy Clin Immunol; 2017 May; 139(5):1411-1421. PubMed ID: 28477720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors to Consider in Prescribing Asthma Biologic Therapies to Children.
    Anderson WC; Banzon TM; Chawes B; Papadopoulos NG; Phipatanakul W; Szefler SJ
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):693-701. PubMed ID: 36646381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic?
    Anderson WC; Szefler SJ
    Ann Allergy Asthma Immunol; 2019 Apr; 122(4):367-372. PubMed ID: 30703438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and immunomodulatory actions of new antiasthmatic agents: Exploring the diversity of biologics in Th2 endotype asthma.
    Okwuofu EO; Yong ACH; Lim JCW; Stanslas J
    Pharmacol Res; 2022 Jul; 181():106280. PubMed ID: 35661709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological treatments for severe asthma.
    Assaf SM; Hanania NA
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):379-386. PubMed ID: 31169594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in Allergy: Are Biologic Treatment Responses in Severe Asthma the Same in Adults and Children?
    Gaberino CL; Bacharier LB; Jackson DJ
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2673-2682. PubMed ID: 37517797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics and severe asthma in children.
    Saxena S; Rosas-Salazar C; Fitzpatrick A; Bacharier LB
    Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):111-118. PubMed ID: 36730217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
    Huffaker MF; Phipatanakul W
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):129-44. PubMed ID: 25459581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologics in severe asthma: the overlap endotype - opportunities and challenges.
    Bakakos A; Loukides S; Usmani OS; Bakakos P
    Expert Opin Biol Ther; 2020 Dec; 20(12):1427-1434. PubMed ID: 32779950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologics in the treatment of asthma in children and adolescents.
    Bacharier LB; Jackson DJ
    J Allergy Clin Immunol; 2023 Mar; 151(3):581-589. PubMed ID: 36702649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaching Current and New Drug Therapies for Pediatric Asthma.
    Anderson WC; Gleason MC; Miyazawa N; Szefler SJ
    Pediatr Clin North Am; 2017 Dec; 64(6):1197-1207. PubMed ID: 29173780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
    Santus P; Saad M; Damiani G; Patella V; Radovanovic D
    Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future of biologics in pediatric asthma: Optimizing response, early introduction, and equitable access to treatment.
    Schepel IRM; Banzon TM; Phipatanakul W
    Ann Allergy Asthma Immunol; 2024 Jan; 132(1):13-20. PubMed ID: 37652232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for new and emerging therapeutics in severe asthma: the role of biologics.
    Kepil Özdemir S; Bavbek S
    Expert Rev Respir Med; 2017 Jun; 11(6):505-512. PubMed ID: 28464704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging care management strategies for severe asthma: integrating biologic therapy.
    Spjut R
    Am J Manag Care; 2022 Sep; 28(11 Suppl):S203-S209. PubMed ID: 36648385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.